OPRI is excited to share a milestone in asthma phenotype recognition!
The ISAR #publication titled, ”Eosinophilic and Non eosinophilic Asthma, An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort” found that >80% patients in severe asthma centres have eosinophilic asthma which is more than previously thought. The eosinophilic phenotype was identified using #ISAR’s Gradient Eosinophilic Phenotype Algorithm, an evidence-based and consensus-driven algorithm using readily available variables in real life. The value of this algorithm, is that physicians can now easily recognize the type of asthma their patients have, identify treatable traits and confidently prescribe phenotype-directed treatments.
With nearly 7000 downloads as of 31 December 2021, it was the TOP downloaded paper on chestjournal.org and ScienceDirect in 2021!
Check out the full article: https://lnkd.in/eWfjXkD
Slide set that offers a quick overview of the article: https://lnkd.in/gkyj7Aw5
International Severe Asthma Registry
